Literature DB >> 22367571

The importance of exercise echocardiography for clinical decision making in primary mitral regurgitation.

Caroline M Van de Heyning1, Julien Magne, Patrizio Lancellotti, Luc A Piérard.   

Abstract

Primary mitral regurgitation is generally an insidious disease with late onset of symptoms. Current European and American guidelines recommend surgery in severe primary mitral regurgitation when symptoms, overt left ventricular dysfunction, pulmonary hypertension or atrial fibrillation, occur. However, recent large studies reported an improved outcome in asymptomatic patients with severe mitral regurgitation referred for early mitral valve repair despite the risk of operative mortality or mitral valve replacement. Moreover, primary mitral regurgitation appears to have an important dynamic character in up to one-third of patients. This article provides an overview of the incremental evidence of the ability of exercise echocardiography to assess the functional repercussions of mitral regurgitation and the identification of high-risk patients who might benefit from early referral for surgery.

Entities:  

Mesh:

Year:  2012        PMID: 22367571     DOI: 10.2459/JCM.0b013e3283515c70

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  3 in total

1.  The role of exercise echocardiography in the management of mitral valve disease.

Authors:  R Jansen; P A M Kracht; M J Cramer; W J Tietge; L A van Herwerden; R J M Klautz; J Kluin; S A J Chamuleau
Journal:  Neth Heart J       Date:  2013-08-20       Impact factor: 2.380

2.  Pulmonary hypertension in left heart disease.

Authors:  Pratishtha Mehra; Vimal Mehta; Rishi Sukhija; Anjan K Sinha; Mohit Gupta; M P Girish; Wilbert S Aronow
Journal:  Arch Med Sci       Date:  2017-07-17       Impact factor: 3.318

3.  Importance of exercise capacity in predicting outcomes and determining optimal timing of surgery in significant primary mitral regurgitation.

Authors:  Peyman Naji; Brian P Griffin; Tyler Barr; Fadi Asfahan; A Marc Gillinov; Richard A Grimm; L Leonardo Rodriguez; Tomislav Mihaljevic; William J Stewart; Milind Y Desai
Journal:  J Am Heart Assoc       Date:  2014-09-11       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.